Registration, Networking and Continental Breakfast

Chair’s Welcome Note – Day 1

Canadian regulation requirements regarding permits for the import or export of cannabis for medical or scientific purposes

• Legislative and regulatory frameworks
• Limited circumstances under which imports/exports are authorized
• Import/Export Permits issuance process

Present by: Alice Gheorghiu,
Manager of Hemp and Import/Export
Controlled Substances and Cannabis Branch, Health Canada
Direction générale des substances contrôlées et du cannabis, Santé Canada

Export of Medical Marijuana to the U.S. and Worldwide

• Legal status of medical marijuana under international law
• Legal status of medical marijuana import/export under international law
• Import permits and requirements
• International Narcotics Control Board reporting requirements
• Export to the United States

Present by: Vincent Sliwoski, Partner, Harris Bricken

Mid-morning Refreshment Break

Import & Export of medicinal cannabis on Latin America

• Law frameworks ( Argentina, Brazil, Chile, Colombia, Uruguay)
• Permits and requirements
• Public bodies involved
• Import/Export for compassionate use

Present by: Daniel Podestá, Partner, Estudio Podestá

Panel Q & A, Discussion

Alice Gheorghiu, Health Canada,
Vincent Sliwoski, Harris Bricken
Daniel Podestá, Estudio Podestá

Lunch

Legalisation of Cannabis in South Africa: High on our list of priorities

Cannabis in South Africa: Regulatory requirements for import/export

Present by: Martha Smit, Partner, Qualified registered nurse and lawyer, Fasken, Johannesburg

Malta – An Ideal Jurisdiction for Medical Cannabis

Present by: Marion Zammit, Malta’s Government economic development agency, responsible for supporting the Medical Cannabis Industry, along with other sectors, Malta Enterprise

Mid-Afternoon Refreshment Break

Import & Export of Medicinal Cannabis in Europe, UK & Australia

Present by: Deepak Anand, MBA, Chief Executive Officer and Director, Materia

GMP Certification and Manufacturing in EU

• Business cases that require GMP
• How long does it take
• Where does GMP start

Present by:
Karina Lahnakoski, Partner, Risk Advisory, CCI Deloitte, Deloitte LLP
Valentina Vaguengueim, Senior Manager, Risk Advisory, CCI Deloitte, Deloitte LLP

Panel Q & A, Discussion

Martha Smit, Fasken, Johannesburg
Marion Zammit, Malta Enterprise
Deepak Anand, Materia
Karina Lahnakoski, CCI Deloitte, Deloitte LLP
Valentina Vaguengueim, CCI Deloitte, Deloitte LLP

Conclusion of Day 1 Conference